Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

PTH-CBD agonists may help regrow hair after chemotherapy.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Breathing in newborn rats is affected differently by hormones based on their sex.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.